Find a Clinical Trial
Filter
A Modified Ketogenic, Anti‐Inflammatory Diet for Patients with High‐Grade Gliomas
Glioblastoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
The ImmuneSense Study
Glioblastoma
All genders
18-70
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Non-Interventional Fresh Tumor Tissue
Glioblastoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology
Home and Bedside Visual Fields
Vision health
All genders
15-80
Recruiting now
Department of Ophthalmology
NRG-BN009
Brain cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ETS3
Vision impairment
All genders
3-9
Recruiting now
Department of Ophthalmology
Infant Vision Health and Prenatal Drug Exposure
Vision health
All genders
0-5
Recruiting now
Department of Obstetrics + Gynecology